Thumbnail Image
Publication

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.

Neoptolemos, J
; 
Moore, M
; 
Cox, T
; 
Valle, Juan W
; 
Palmer, D
; 
McDonald, A
; 
Carter, R
; 
Tebbutt, N
; 
Dervenis, C
; 
Smith, D
... show 10 more
Citations
Altmetric:
Abstract
Patients with periampullary adenocarcinomas undergo the same resectional surgery as that of patients with pancreatic ductal adenocarcinoma. Although adjuvant chemotherapy has been shown to have a survival benefit for pancreatic cancer, there have been no randomized trials for periampullary adenocarcinomas.
Authors
Neoptolemos, J
Moore, M
Cox, T
Valle, Juan W
Palmer, D
McDonald, A
Carter, R
Tebbutt, N
Dervenis, C
Smith, D
Glimelius, B
Charnley, R
Lacaine, F
Scarfe, A
Middleton, M
Anthoney, A
Ghaneh, P
Halloran, C
Lerch, M
Oláh, A
Rawcliffe, C
Verbeke, C
Campbell, F
Büchler, M
Affiliation
Institute of Translational Medicine, Liverpool Cancer Trials Unit, Liverpool Cancer Research United Kingdom Centre, University of Liverpool, Liverpool, England, United Kingdom. j.p.neoptolemos@liverpool.ac.uk
Description
Date
2012-07-11
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
From UNPAYWALL
Adobe PDF, 248.48 KB
Keywords
Type
Article
Citation
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. 2012, 308 (2):147-56 JAMA
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/248616
Embedded videos